Patents-Review.com
ClassID:

109280 ⎘

C12N2501/05 - CPC Classification

Classification description:

Active agents used in cell culture processes, e.g. differentation Adjuvants

Sub-classes:
Recent Application in this class:
#1
20250381271
2025-12-18

CELL SYSTEM AND APPLICATION THEREOF, AND METHOD FOR ACTIVATING BROAD-SPECTRUM CANCER CELL-SPECIFIC T CELL

 #2
20240271092
2024-08-15

Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies

 #3
20220282215
2022-09-08

Tumor-infiltrating lymphocytes for adoptive cell therapy

 #4
20220064584
2022-03-03

DELIVERY OF BIOMOLECULES TO IMMUNE CELLS

 #5
20210054335
2021-02-25

METHOD FOR INCREASING DENDRITIC CELL MIGRATION ABILITY, AND USE THEREOF

 #6
20200360497
2020-11-19

COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS

 #7
20200216806
2020-07-09

Allogeneic Dendritic Cells For Use In Cancer Treatment

 #8
20190224302
2019-07-25

Generation of HPV-specific T-cells

 #9
20190177693
2019-06-13

Tumor-infiltrating lymphocytes for adoptive cell therapy

 #10
20190144825
2019-05-16

Methods of treating cancer using cell based therapies

 #11
20180250379
2018-09-06

Generation of HPV-specific T-cells

 #12
20180142198
2018-05-24

Delivery of biomolecules to immune cells

 #13
20170296639
2017-10-19

METHOD FOR PREPARING DENDRITIC CELL LOADED WITH ANTIGEN

 #14
20170274069
2017-09-28

METHOD FOR THE CANCER TREATMENT AND PREVENTION OF METASTATIC DISEASE

 #15
20170087233
2017-03-30

Compositions and methods for producing dendritic cells

 #16
20170022481
2017-01-26

Method for generating high-titer hepatitis E virus stocks and titration assay for hepatitis E virus

 #17
20170007668
2017-01-12

Pharmaceutical Composition Comprising Stem Cells Treated with NOD2 Agonist or Culture Thereof for Prevention and Treatment of Immune Disorders and Inflammatory Diseases

 #18
20160250248
2016-09-01

Method for generation of broadly neutralizing anti-pathogen antibodies

 #19
20150366910
2015-12-24

Natural killer cells from placenta

 #20
20150166954
2015-06-18

Cell selection method and cells obtained therefrom

 #21
20150125956
2015-05-07

Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same

 #22
20140370044
2014-12-18

Modified epitopes for boosting CD4+ T-cell responses

 #23
20140356893
2014-12-04

COMPOSITIONS AND METHODS FOR USING PLATELET-RICH PLASMA FOR DRUG DISCOVERY, CELL NUCLEAR REPROGRAMMING, PROLIFERATION OR DIFFERENTIATION

 #24
20140072596
2014-03-13

Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases

 #25
20130209422
2013-08-15

Pharmaceutical composition comprising stem cells treated with NOD2 agonist or culture thereof for prevention and treatment of immune disorders and inflammatory diseases

 #26
20120269839
2012-10-25

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

 #27
20120251561
2012-10-04

ADMINISTRATION OF DENDRITIC CELLS PARTIALLY MATURED IN VITRO FOR THE TREATMENT OF TUMORS

 #28
20100303868
2010-12-02

EX VIVO, FAST AND EFFICIENT PROCESS TO OBTAIN ACTIVATED ANTIGEN-PRESENTING CELLS THAT ARE USEFUL FOR THERAPIES AGAINST CANCER AND IMMUNE SYSTEM-RELATED DISEASES

 #29
20100291118
2010-11-18

Class of Gamma Delta T Cells Activators and Use Thereof

 #30
20100021488
2010-01-28

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

 #31
20080075732
2008-03-27

Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

 #32
20070154877
2007-07-05

Method for the direct culture of dendritic cells without a preceding centrifugation step

 #33
20060057120
2006-03-16

Administration of dendritic cells partially matured in vitro for the treatment of tumors